DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Neuraminidase inhibitor
Neuraminidase inhibitor
Antiviral Agents Active Against Influenza a Viruses
Summary of Neuraminidase Amino Acid Substitutions Associated with Reduced Inhibition by Neuraminidase Inhibitors
Journal Pre-Proof
Influenza Antiviral Medications: Summary for Clinicians
In Vitro Activity of Favipiravir and Neuraminidase Inhibitor Combinations Against Oseltamivir-Sensitive and Oseltamivir-Resistant Pandemic Influenza a (H1N1) Virus
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018
Antivirals for COVID-19 Posted May 7, 2020
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017
SARS-Cov-2: an Update on Potential Antivirals in Light of SARS-Cov Antiviral Drug Discoveries
A Computational Approach to Aid Clinicians in Selecting Anti-Viral
Pharmacological Approaches to the Treatment of COVID-19 Patients
Text and Network-Mining for COVID-19 Intervention Studies
Neuraminidase Inhibitors for Treatment of Influenza a and B Infections
Peramivir Fact Sheet for Health Care Providers
A Potential Protective Role Against COVID-19 Through
Anti-Influenza Drugs Study of Efficacy and Mechanisms of a Novel Lung
(2001). Position Statement; Global Neuraminidase Inhibitor
Investigation of Antiviral State Mediated by Interferon-Inducible
Top View
Evolution in the Therapeutics of Respiratory Viral Infections
Uses and Administration Adverse Effects Profile Profile Profile Uses
Supplementary Material (ESI) for Natural Product Reports
Ostavimir Is Ineffective Against COVID-19: in Silico Assessment,In Vitro And
Approved Antiviral Drugs Over the Past 50 Years
Antiviral Treatment of COVID-19: a Clinical Pharmacology Narrative Review
Understanding Drug Resistance and Antibody Neutralization Escape in Antivirals: a Dissertation
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives
New Antivirals and Drug Resistance
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2019
Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins
Antiviral Therapy and Prophylaxis for Influenza in Children Committee on Infectious Diseases Pediatrics 2007;119;852 DOI: 10.1542/Peds.2007-0224
Antivirals Targeting the Surface Glycoproteins of Influenza Virus
31St ICPE Final Program
Cell Clearing Systems As Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis
Is the Neuraminidase Inhibitor Tamiflu Effective in the Treatment of Influenza? by Eliyakim Hershkop Eliyakim Hershkop Graduated in June 2015 with a B.S
Download Special Issue
Assessment Report on Hedera Helix L., Folium Final
Expert Opinion on Neuraminidase Inhibitors for the Prevention and Treatment of Influenza
Antiviral Drug Sensitivity of Influenza Virus Isolates Collected from Migratory Birds Justin D
Review Article Eicosanoids and Respiratory Viral Infection: Coordinators of Inflammation and Potential Therapeutic Targets
Neuraminidase Inhibitors As Anti-Influenza Virus Agents
2013 March (127): Treatment Guidelines
Covid-19: UK Launches Antivirals Taskforce to Deliver Home
G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Actions
A Randomized Controlled Trial
(12) United States Patent (10) Patent No.: US 6,436,924 B2 Poppe Et Al
Current Landscape and Future Prospects of Antiviral Drugs Derived from Microbial Products
Nethmap 2015 MARAN 2015
Original Article Surveillance for Neuraminidase-Inhibitor-Resistant Influenza Viruses in Japan, 1996–2007
Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza Randomized Controlled Trials for Prevention and Treatment
Antiviral Medications for Seasonal Influenza: Information for Health Care Providers, 2019
PCSK9 Inhibitors: What Can We Expect in 2015?
Clinical Use of Approved Influenza Antivirals
New Treatment Strategies for Influenza Luis Del Carpio-Orantes*
Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
Influenza Neuraminidase Inhibitors
Eicosanoids and Respiratory Viral Infection: Coordinators of Inflammation and Potential Therapeutic Targets